AAAAAA
Results: 1-25/55
Authors:
Remberger, M
Mattsson, J
Ringden, O
Citation: M. Remberger et al., Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation, PEDIAT TRAN, 5(4), 2001, pp. 285-292
Authors:
Tollemar, J
Klingspor, L
Ringden, O
Citation: J. Tollemar et al., Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children, CL MICRO IN, 7, 2001, pp. 68-79
Authors:
Carlens, S
Remberger, M
Aschan, J
Ringden, O
Citation: S. Carlens et al., The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse, BIOL BLOOD, 7(1), 2001, pp. 31-38
Authors:
Lindton, B
Tolfvenstam, T
Norbeck, O
Markling, L
Ringden, O
Westgren, M
Broliden, K
Citation: B. Lindton et al., Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro, FETAL DIAGN, 16(1), 2001, pp. 26-31
Authors:
Remberger, M
Aschan, J
Lonnqvist, B
Carlens, S
Gustafsson, B
Hentschke, P
Klaesson, S
Mattsson, J
Ljungman, P
Ringden, O
Citation: M. Remberger et al., An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation, EUR J HAEMA, 66(1), 2001, pp. 50-56
Authors:
Remberger, M
Aschan, J
Barkholt, L
Tollemar, J
Ringden, O
Citation: M. Remberger et al., Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin, CLIN TRANSP, 15(3), 2001, pp. 147-153
Authors:
Saarinen-Pihkala, UM
Gustafsson, G
Ringden, O
Heilmann, C
Glomstein, A
Lonnerholm, G
Abrahamsson, J
Bekassy, AN
Schroeder, H
Mellander, L
Citation: Um. Saarinen-pihkala et al., No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children withacute lymphoblastic leukemia in second remission, J CL ONCOL, 19(14), 2001, pp. 3406-3414
Authors:
Sandstrom, M
Karlsson, MO
Ljungman, P
Hassan, Z
Jonsson, EN
Nilsson, C
Ringden, O
Oberg, G
Bekassy, A
Hassan, M
Citation: M. Sandstrom et al., Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients, BONE MAR TR, 28(7), 2001, pp. 657-664
Authors:
Hassan, Z
Ljungman, P
Ringden, O
Winiarski, J
Nilsson, C
Aschan, J
Whitley, HR
Hassan, M
Citation: Z. Hassan et al., Pharmacokinetics of liposomal busulphan in man, BONE MAR TR, 27(5), 2001, pp. 479-485
Authors:
Januszkiewicz, A
Essen, P
McNurlan, MA
Ringden, O
Garlick, PJ
Wernerman, J
Citation: A. Januszkiewicz et al., Determination of in vivo protein synthesis in human T lymphocytes, CLIN NUTR, 20(2), 2001, pp. 181-182
Authors:
Remberger, M
Aschan, J
Lonnqvist, B
Carlens, S
Gustafsson, B
Hentschke, P
Klaesson, S
Mattsson, J
Ljungman, P
Ringden, O
Citation: M. Remberger et al., An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1769-1770
Authors:
Barkholt, L
Hentschke, P
Zetterquist, H
Mattsson, J
Uzunel, M
Wersall, P
Martola, J
Albin, N
Aschan, J
Wijkstrom, H
Tillegard, A
Oman, S
Wernerson, A
Niederwieser, D
Thorne, A
Ringden, O
Citation: L. Barkholt et al., An allogeneic anti-cancer effect after hematopoietic stem cell transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1862-1864
Authors:
Mattsson, J
Uzunel, M
Remberger, M
Ringden, O
Citation: J. Mattsson et al., T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation, TRANSPLANT, 71(3), 2001, pp. 433-439
Authors:
Januszkiewicz, A
Essen, P
McNurlan, MA
Ringden, O
Garlick, PJ
Wernerman, J
Citation: A. Januszkiewicz et al., A combined stress hormone infusion decreases in vivo protein synthesis in human T lymphocytes in healthy volunteers, METABOLISM, 50(11), 2001, pp. 1308-1314
Authors:
Mattsson, J
Uzunel, M
Remberger, M
Tammik, L
Omazic, B
Levitsky, V
Zou, JZ
Hentschke, P
Ringden, O
Citation: J. Mattsson et al., Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation, CLIN EXP IM, 123(1), 2001, pp. 162-169
Authors:
Remberger, M
Ringden, O
Blau, IW
Ottinger, H
Kremens, B
Kiehl, MG
Aschan, J
Beelen, DW
Basara, N
Kumlien, G
Fauser, AA
Runde, V
Citation: M. Remberger et al., No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors, BLOOD, 98(6), 2001, pp. 1739-1745
Authors:
Uzunel, M
Mattsson, J
Jaksch, M
Remberger, M
Ringden, O
Citation: M. Uzunel et al., The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia, BLOOD, 98(6), 2001, pp. 1982-1984
Authors:
Socie, G
Clift, RA
Blaise, D
Devergie, A
Ringden, O
Martin, PJ
Remberger, M
Deeg, HJ
Ruutu, T
Michallet, M
Sullivan, KM
Chevret, S
Citation: G. Socie et al., Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies, BLOOD, 98(13), 2001, pp. 3569-3574
Authors:
Filipovich, AH
Stone, JV
Tomany, SC
Ireland, M
Kollman, C
Pelz, CJ
Casper, JT
Cowan, MJ
Edwards, JR
Fasth, A
Gale, RP
Junker, A
Kamani, NR
Loechelt, BJ
Pietryga, DW
Ringden, O
Vowels, M
Hegland, J
Williams, AV
Klein, JP
Sobocinski, KA
Rowlings, PA
Horowitz, MM
Citation: Ah. Filipovich et al., Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant registry and the National Marrow Donor Program, BLOOD, 97(6), 2001, pp. 1598-1603
Authors:
Lindton, B
Markling, L
Ringden, O
Kjaeldgaard, A
Gustafson, O
Westgren, M
Citation: B. Lindton et al., Mixed lymphocyte culture of human fetal liver cells, FETAL DIAGN, 15(2), 2000, pp. 71-78
Authors:
Mattsson, J
Uzunel, M
Remberger, M
Ljungman, P
Kimby, E
Ringden, O
Zetterquist, H
Citation: J. Mattsson et al., Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease, LEUKEMIA, 14(2), 2000, pp. 247-254
Authors:
Bagesund, M
Richter, S
Agren, B
Ringden, O
Dahllof, G
Citation: M. Bagesund et al., Scintigraphic study of the major salivary glands in pediatric bone marrow transplant recipients, BONE MAR TR, 26(7), 2000, pp. 775-779
Authors:
Svahn, BM
Bjurman, B
Myrback, KE
Aschan, J
Ringden, O
Citation: Bm. Svahn et al., Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? - A pilot trial, BONE MAR TR, 26(10), 2000, pp. 1057-1060
Authors:
Hassan, M
Ljungman, P
Ringden, O
Hassan, Z
Oberg, G
Nilsson, C
Bekassy, A
Bielenstein, M
Abdel-Rehim, M
Georen, S
Astner, L
Citation: M. Hassan et al., The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy andtherapy-related toxicity, BONE MAR TR, 25(9), 2000, pp. 915-924
Authors:
Ringden, O
Remberger, M
Lehmann, S
Hentschke, P
Mattsson, J
Klaesson, S
Aschan, J
Citation: O. Ringden et al., N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation, BONE MAR TR, 25(9), 2000, pp. 993-996